Utility of glomerular and tubular markers in establishing early renal involvement in type II diabetes mellitus

Clinical Biochemistry

Volumn 29, Issue 4, 1996, Pages 385-388

  Bedir, Abdulkerim ^a   Özener, I Çetin ^b   Adam, Bahattin ^a   Emerk, Kaya ^b  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

1,9 DIMETHYLMETHYLENE BLUE; ALBUMIN; AMYLASE ISOENZYME; CYTOSOL AMINOPEPTIDASE; GLUCOSE; GLYCOSAMINOGLYCAN; GLYCOSYLATED HEMOGLOBIN; HEPARAN SULFATE; REAGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYMURIA; FEMALE; GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; HUMAN; KIDNEY TUBULE FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0029950550     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-9120(96)00004-5     Document Type: Article

References (12)

1. 1. Knowles HC. Magnitude of the renal failure problem in diabetic patients. Kidney Int 1974; 6(Suppl): 2-4.
2. 2. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathy. Am J Med 1982; 72: 375-380.
3. 3. Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M. Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int 1988; 33: 100-106.
4. 4 proteoglycan by heparin from glomeruli of streptozotocin-induced diabetic rats. Diabetes 1989; 38: 130-139.
5. 5. Kjellén L, Bielefeld D, Höök M. Reduced sulfatation of liver heparan sulfate in experimentally diabetic rats. Diabetes 1983; 32: 337-342.
6. 6. Kanwar YS, Linker A, Farquhar MG. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol 1980; 86: 688-693.
7. 7. Piccoli A, Zaninotto M, Mussap M, et al. Pancreatic to salivary amylase clearance in assessing glomerular charge selectivity. Progr Med Lab 1990; 4: 452.
8. 8. Recio F, Villamil F, Recio C, Ferrer C. Utility of filtration markers to monitor the quality of glomerular function. Clin Nephrol 1992; 38(Suppl 1): S8-S13.
9. 9. Jung K, Scholz D. An optimized assay of alanine aminopeptidase activity in urine. Clin Chem 1980; 26: 1251-4.
10. 10. De Jong JGN, Wevers RA, Laarakkers C, Poorthuis BJHM. Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses. Clin Chem 1989; 35: 1472-1477.
11. 11. Hofmann W, Guder WG. A diagnostic program for quantitative analysis of proteinuria. J Clin Chem Clin Biochem 1989; 27: 589-600.
12. 12. Guzman NJ, Crews FT. Regulation of inositol transport by glucose and protein kinase C in mesangial cells. Kidney Int 1992; 42: 33-40.